Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

NCT00888082 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Ovarian Function

Interventions

DRUG: Goserelin acetate

Sponsor

AstraZeneca